OXUR Share Price Performance
€0.0076
-0.23 (-96.83%)
Price €0.0076
Share Pricen/a
Oxurion NV Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
OXUR Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Oxurion NV Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Apr 03, 2026
- 0.031
- -650.00%
- 97,950.00%
- -90.2%
About OXUR
- Founded
- 1991
- Employees
- 11
- CEO
- WebsiteView website
Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness in Belgium. The company is developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.